[Predictive factors of maintain of employment and return to work after cancer].
Facteurs prédictifs de maintien en emploi et de retour au travail après un cancer.
Adult
Breast Neoplasms
/ epidemiology
Colonic Neoplasms
/ epidemiology
Employment
/ statistics & numerical data
Female
Humans
Male
Middle Aged
Neoplasms
/ epidemiology
Occupations
Return to Work
/ statistics & numerical data
Sex Factors
Sick Leave
/ statistics & numerical data
Tunisia
/ epidemiology
Consultation
Médecine du travail
Neoplasms
Occupational medicine
Reprise du travail
Return to work
Tumeurs
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
15
07
2020
revised:
04
10
2020
accepted:
14
10
2020
pubmed:
19
1
2021
medline:
7
4
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
Return-to-work after cancer depends on several factors related to the disease but also other socio-professional factors. The primary aim of this study was to identify socio-demographic, disease related and professional factors influencing the return-to-work process. It was a prospective and descriptive study reporting the return-to-work process in 89 cancer patients, in a professional activity age, who had cancer treatment and a follow up in the Oncology department in Tahar Maamouri Teaching Hospital of Nabeul, between September 2015 to December 2019. Our study included 89 patients. Mean age was 45 years±8. The population was predominantly feminine (59 %). They were employees in 45 % of cases. Private professional sectors included 60 % of all patients. An open-ended contract was performed in 87 % of cases. Most frequent primary tumors were breast tumors (45 %) and colon tumors (20 %). Thirty-four patients went back to work after recovery. Seventy-nine percent of them were female patients and 70 % had breast cancer. Predictive factors identified in univariate statistical analysis and correlated to return-to-work were gender (P=0.002), occupation (P<10 Our study underlined a need to create a pluridisciplinary platform unifying collaborators among oncologists and occupational health professionals in order to enhance professional reintegration process and to hold patient's professional equilibrium after cancer recovery.
Sections du résumé
BACKGROUND
BACKGROUND
Return-to-work after cancer depends on several factors related to the disease but also other socio-professional factors. The primary aim of this study was to identify socio-demographic, disease related and professional factors influencing the return-to-work process.
METHODS
METHODS
It was a prospective and descriptive study reporting the return-to-work process in 89 cancer patients, in a professional activity age, who had cancer treatment and a follow up in the Oncology department in Tahar Maamouri Teaching Hospital of Nabeul, between September 2015 to December 2019.
RESULTS
RESULTS
Our study included 89 patients. Mean age was 45 years±8. The population was predominantly feminine (59 %). They were employees in 45 % of cases. Private professional sectors included 60 % of all patients. An open-ended contract was performed in 87 % of cases. Most frequent primary tumors were breast tumors (45 %) and colon tumors (20 %). Thirty-four patients went back to work after recovery. Seventy-nine percent of them were female patients and 70 % had breast cancer. Predictive factors identified in univariate statistical analysis and correlated to return-to-work were gender (P=0.002), occupation (P<10
CONCLUSION
CONCLUSIONS
Our study underlined a need to create a pluridisciplinary platform unifying collaborators among oncologists and occupational health professionals in order to enhance professional reintegration process and to hold patient's professional equilibrium after cancer recovery.
Identifiants
pubmed: 33455735
pii: S0007-4551(20)30496-3
doi: 10.1016/j.bulcan.2020.10.019
pii:
doi:
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
272-283Informations de copyright
Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.